Fed. Circ. Backs ITC's Refusal To Probe False Ad Claims
The Federal Circuit on Wednesday affirmed the U.S. International Trade Commission's decision not to investigate a false advertising complaint that Amarin Pharma Inc. filed against rivals, ruling the ITC can refuse...To view the full article, register now.
Already a subscriber? Click here to view full article